Franklin Resources
VERA icon

Franklin Resources’s Vera Therapeutics VERA Stock Holding History

Franklin Resources’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,851
Closed -$316K – 3339
2026
Q1 		$316K Buy
7,851
+280
+4% +$12.1K ﹤0.01% 2643
2025
Q4 		$383K Sell
7,571
-1,507
-17% -$53.5K ﹤0.01% 2517
2025
Q3 		$264K Buy
+9,078
New +$210K ﹤0.01% 2723
2024
Q4 		– Sell
-8,746
Closed -$369K – 3028
2024
Q3 		$369K Sell
8,746
-5,859
-40% -$222K ﹤0.01% 2415
2024
Q2 		$528K Buy
14,605
+2,321
+19% +$92.1K ﹤0.01% 2201
2024
Q1 		$530K Buy
+12,284
New +$438K ﹤0.01% 2215

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources's VERA Position: Q2 2026 in Review

Franklin Resources sold out of Vera Therapeutics (VERA) in Q2 2026, closing a stake of 7,851 shares — an estimated $316K sold.

Franklin Resources first reported a position in VERA in Q1 2024 and held it in 6 quarters. The position peaked at $530K in Q1 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Franklin Resources reported no remaining Vera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Franklin Resources sold 7,851 Vera Therapeutics shares in Q2 2026, an estimated $316K.
  • Franklin Resources first reported a position in Vera Therapeutics in Q1 2024 and held it in 6 quarters.
  • Franklin Resources's Vera Therapeutics position peaked at $530K in Q1 2024.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.